Search
Feed aggregator
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins 5/28/2024
30 Years After Genetic Discovery, Huntington’s Patients Still Waiting
30 Years After Genetic Discovery, Huntington’s Patients Still Waiting 5/28/2024
Despite Progress, ADCs Still Stalled in Non-Small Cell Lung Cancer
Despite Progress, ADCs Still Stalled in Non-Small Cell Lung Cancer 5/28/2024
Precision Medicine and Novel Approaches on Cusp of Breaking Through in Psychiatry
Precision Medicine and Novel Approaches on Cusp of Breaking Through in Psychiatry 5/28/2024
Opinion: How to Make Today’s Clinical Research More Efficient
Opinion: How to Make Today’s Clinical Research More Efficient 5/28/2024
Lilly Invests Another $5.3B in Indiana Plant to Boost Tirzepatide Manufacturing
Lilly Invests Another $5.3B in Indiana Plant to Boost Tirzepatide Manufacturing 5/24/2024
Novo Nordisk’s Semaglutide Cuts Death Risk in Diabetics with CKD in Phase III Trial
Novo Nordisk’s Semaglutide Cuts Death Risk in Diabetics with CKD in Phase III Trial 5/24/2024
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial 5/24/2024
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study 5/24/2024
Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far?
Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far? 5/24/2024
ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data
ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data 5/24/2024
Zealand Touts Phase I Results for GLP-1, GLP-2 Candidate Despite Modest Weight Loss
Zealand Touts Phase I Results for GLP-1, GLP-2 Candidate Despite Modest Weight Loss 5/24/2024
Takeda Joins Hot Molecular Glue Market With $1.2B Deal
Takeda Joins Hot Molecular Glue Market With $1.2B Deal 5/23/2024
Pfizer Targets Another $1.5B in Cost Cuts By End of 2027
Pfizer Targets Another $1.5B in Cost Cuts By End of 2027 5/23/2024
Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche
Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche 5/23/2024
Orna Buys Competing RNA Biotech ReNAgade After Series A Financing
Orna Buys Competing RNA Biotech ReNAgade After Series A Financing 5/23/2024
FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm
FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm 5/23/2024
Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program
Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program 5/23/2024
Moderna Among Companies Partnering With OpenAI to Boost AI Efforts
Moderna Among Companies Partnering With OpenAI to Boost AI Efforts 5/23/2024
BioSpace x DIA: Navigating the Emergence of CGT Combination Products
BioSpace x DIA: Navigating the Emergence of CGT Combination Products 5/23/2024
World Pharma News
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders
- A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy
- Common gout drug may reduce risk of heart attack and stroke
- New nasal vaccine has potential to transform respiratory disease prevention
- MIT research finds particles that enhance mRNA delivery could reduce vaccine dosage and costs